These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 13827287)
1. Studies on a new hypotensive agent: bretylium tosylate. GENEST J; DUFAULT G; PIGEON G; DAVIGNON J; BIRON P; TRUDEL J Can Med Assoc J; 1960 Apr; 82(17):872-7. PubMed ID: 13827287 [No Abstract] [Full Text] [Related]
2. The circul atory effects of bretylium tosylate and guanethidine. TAYLOR SH; DONALD KW Lancet; 1960 Aug; 2(7147):389-94. PubMed ID: 13837199 [No Abstract] [Full Text] [Related]
3. [Influence of bretylium tosylate on renal function in the course of arterial hypertension]. ZUCCHELLI P; DALMASTRI G G Clin Med; 1961 Jan; 42():1-14. PubMed ID: 13788864 [No Abstract] [Full Text] [Related]
4. Effects of brachial arterial infusion of bretylium tosylate on hand blood flow. FRENCH EB; MATTHEWS MB Clin Sci; 1961 Oct; 21():151-5. PubMed ID: 13895014 [No Abstract] [Full Text] [Related]
5. Effects of bretylium tosylate on blood-pressure, cardiac output, and renal function in hypertension. DOYLE AE; FRASER JR; SMITH PK Br Med J; 1960 Aug; 2(5196):422-5. PubMed ID: 13817928 [No Abstract] [Full Text] [Related]
6. [Bretylium tosylate (darenthin) a new hypotensive agent]. CLAUSEN E; HILDEN T; KROGSGAARD AR Ugeskr Laeger; 1960 Aug; 122():1103-9. PubMed ID: 13693948 [No Abstract] [Full Text] [Related]
7. Bretylium tosylate: long-term clinical trial of new hypotensive agent. STUCKEY D Med J Aust; 1960 Jul; 47(2)():166-8. PubMed ID: 13835383 [No Abstract] [Full Text] [Related]
8. Clinical and experimental studies on bretylium tosylate, a new hypotensive agent. HAYDEN JG; BOAKE WC Med J Aust; 1960 Apr; 47(1)():528-32. PubMed ID: 14400312 [No Abstract] [Full Text] [Related]
11. Selective inhibition of the sympathetic nervous system in man with bretylium tosylate, a new antihypertensive agent. FREIS ED; SUGIURA T; LIPTAK D Circulation; 1960 Aug; 22():191-7. PubMed ID: 13849851 [No Abstract] [Full Text] [Related]
12. Clinical experience with bretylium tosylate. LEWIS JA Can Med Assoc J; 1960 Apr; 82(17):877-81. PubMed ID: 14416531 [No Abstract] [Full Text] [Related]
13. The initial pressor actions of bretylium tosylate and guanethidine sulfate and their relation to release of catecholamines. GILLIS CN; NASH CW J Pharmacol Exp Ther; 1961 Oct; 134():1-7. PubMed ID: 13898659 [No Abstract] [Full Text] [Related]
14. Bretylium tosylate as an antihypertensive drug. HURLEY RE; PAGE IH; DUSTAN HP J Am Med Assoc; 1960 Apr; 172():2081-3. PubMed ID: 14405524 [No Abstract] [Full Text] [Related]
15. Bretylium tosylate in the treatment of hypertension. BAUER CE Jpn Circ J; 1961 May; 25():487-92. PubMed ID: 13865849 [No Abstract] [Full Text] [Related]
16. Comparison of bretylium tosylate with guanethidine in the treatment of severe hypertension. EVANSON JM; SEARS HT Lancet; 1960 Aug; 2(7147):387-9. PubMed ID: 13821025 [No Abstract] [Full Text] [Related]
17. The effects of bretylium tosylate on the vascular responses of rabbits to Escherichia coli endotoxin. ARSECULERATNE SN Indian J Med Sci; 1962 Jun; 16():508-15. PubMed ID: 13862608 [No Abstract] [Full Text] [Related]
19. Some pharmacological actions of bretylium and guanethidine. VERNIKOS-DANELLIS J; ZAIMIS E Lancet; 1960 Oct; 2(7154):787-8. PubMed ID: 13780968 [No Abstract] [Full Text] [Related]
20. Bretylium and guanethidine: two new drugs producing specific blockade of the sympathetic nervous system. FREIS ED Heart Bull; 1960; 9():88-9. PubMed ID: 13824829 [No Abstract] [Full Text] [Related] [Next] [New Search]